CVS Health Corporation $CVS Shares Acquired by Legacy Capital Group California Inc.

Legacy Capital Group California Inc. raised its stake in CVS Health Corporation (NYSE:CVS) by 37.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,260 shares of the pharmacy operator’s stock after buying an additional 5,510 shares during the quarter. Legacy Capital Group California Inc.’s holdings in CVS Health were worth $1,455,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Hamlin Capital Management LLC acquired a new stake in CVS Health in the fourth quarter valued at approximately $160,844,000. Capitolis Liquid Global Markets LLC acquired a new position in CVS Health in the third quarter valued at $11,308,000. State Street Corp grew its stake in CVS Health by 2.1% during the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after buying an additional 1,245,457 shares during the last quarter. National Bank of Canada FI grew its position in shares of CVS Health by 50.3% during the third quarter. National Bank of Canada FI now owns 1,770,840 shares of the pharmacy operator’s stock worth $133,495,000 after acquiring an additional 593,015 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH increased its stake in CVS Health by 2.9% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 725,189 shares of the pharmacy operator’s stock valued at $57,551,000 after purchasing an additional 20,217 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 1.8%

Shares of NYSE CVS opened at $105.97 on Tuesday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. The stock’s 50 day simple moving average is $97.36 and its 200 day simple moving average is $84.41. The company has a market cap of $135.21 billion, a price-to-earnings ratio of 46.68, a price-to-earnings-growth ratio of 1.02 and a beta of 0.61. CVS Health Corporation has a 12-month low of $58.50 and a 12-month high of $106.40.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.21 by $0.36. The company had revenue of $100.43 billion during the quarter, compared to analysts’ expectations of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.25 earnings per share. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities research analysts expect that CVS Health Corporation will post 7.44 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd will be issued a dividend of $0.665 per share. The ex-dividend date is Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.5%. CVS Health’s dividend payout ratio (DPR) is currently 117.18%.

Insider Buying and Selling

In related news, Director Larry Robbins sold 1,983,538 shares of the stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $94.45, for a total value of $187,345,164.10. Following the completion of the transaction, the director owned 6,213,261 shares of the company’s stock, valued at $586,842,501.45. This represents a 24.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the sale, the executive vice president owned 10,133 shares in the company, valued at $907,714.14. This represents a 87.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,441,551 shares of company stock worth $323,703,977 over the last three months. 0.85% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CVS has been the topic of several recent research reports. Robert W. Baird boosted their price objective on shares of CVS Health from $92.00 to $94.00 and gave the company an “outperform” rating in a research note on Wednesday, April 15th. UBS Group lifted their price objective on CVS Health from $100.00 to $115.00 and gave the stock a “buy” rating in a report on Monday, June 8th. Truist Financial upped their price target on shares of CVS Health from $102.00 to $108.00 and gave the company a “buy” rating in a report on Monday, June 1st. Wells Fargo & Company increased their price objective on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research note on Monday. Finally, Royal Bank Of Canada raised their target price on shares of CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research report on Thursday. Twenty-one research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $103.64.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.